The new wave of weight-loss drugs, known as GLP-1 agonists, could transform societies by significantly reducing obesity rates and improving overall health.
'Short of some crazy unfortunate side effect, this is going to change the world,' says Chin Hur, emphasizing the potential impact of semaglutide on health.
Efforts to model the future impacts of GLP-1 drugs involve uncertainty due to high costs, long-term biological effects, and behavioral changes.
'The spillover impacts of obesity are enormous,' warns Alison Sexton Ward, stressing the extensive consequences of obesity on society when addressing the future.
Collection
[
|
...
]